Stock Report

Download full stock data and analysis for free Last Updated: 23-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Dr. Reddy'S Labs Peer Comparison

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: DRREDDY | BSE: 500124

₹1,211.00

up-down-arrow ₹12.70 (1.06%)

As on 22-Sep-2026IST

Market cap

info icon

₹1,01,163 Cr

Revenue (TTM)

info icon

₹33,228 Cr

P/E Ratio

info icon

31.4

P/B Ratio

info icon

2.6

Div. Yield

info icon

0.7 %

Edit peer-selector-edit
Dr. Reddy'S Labs Zydus Lifesciences Aurobindo Pharma Lupin Mankind Pharma
Market cap (₹ Cr)
 1,01,163 1,15,810 97,642 96,950 1,02,410
Revenue (₹ Cr)
 33,228 28,592 34,935 29,967 14,738
Net Profit (₹ Cr)
 3,169.30 4,492.20 3,712.74 5,551.01 2,055.11
Net Margin (%)
 9.15 14.92 10.42 18.23 13.64
RoE (%)
 8.72 18.78 10.38 28.32 13.60
Price to Earnings
 31.40 25.66 26.30 17.54 50.14
Price-To-Book
 2.65 4.30 2.51 4.07 6.09

Income Statement (₹ Cr)

Dr. Reddy'S Labs Zydus Lifesciences Aurobindo Pharma Lupin Mankind Pharma
Operating Revenue arrow
33,227.90 28,591.70 34,935.29 29,966.58 14,737.88
Total Income arrow
34,650.70 30,111.40 35,624.79 30,442.31 15,061.79
Total Expenditure arrow
28,088.10 21,334.70 27,850.01 20,428.27 10,911.05
EBITDA arrow
5,139.80 7,257.00 7,085.28 9,538.31 3,826.83
Depreciation arrow
2,119.30 1,724.60 1,859.31 1,529.37 893.20
EBIT arrow
3,020.50 5,532.40 5,225.97 8,008.94 2,933.63
Interest arrow
416.30 510.20 387.88 452.37 578.61
Other Income arrow
1,422.80 1,519.70 689.50 475.73 323.91
Exceptional Items arrow
0.00 -534.80 -105.51 -557.91 -129.75
Profit before Tax arrow
4,027.00 6,007.10 5,422.08 7,474.39 2,549.18
Provision for Tax arrow
857.70 1,514.90 1,709.34 1,923.38 494.07
Profit after Tax arrow
3,169.30 4,492.20 3,712.74 5,551.01 2,055.11

Liabilities (₹ Cr)

Dr. Reddy'S Labs Zydus Lifesciences Aurobindo Pharma Lupin Mankind Pharma
Shareholder's Funds arrow
37,891.50 27,111.40 37,890.97 22,448.27 16,300.34
Minority Interest arrow
38.90 -79.70 1.76 -22.18 -24.90
Non-Current Liabilities arrow
3,145.10 7,112.50 2,580.33 3,200.22 5,011.23
Current Liabilities arrow
16,747.40 15,711.90 18,039.01 12,651.24 6,507.25
Total Liabilities arrow
56,576.70 50,672.60 58,196.15 38,146.06 27,754.83

Assets (₹ Cr)

Dr. Reddy'S Labs Zydus Lifesciences Aurobindo Pharma Lupin Mankind Pharma
Non-Current Assets arrow
27,204.00 31,677.20 24,040.45 11,888.82 20,274.65
Current Assets arrow
30,179.30 19,906.10 32,708.75 24,027.38 6,954.20
Total Assets arrow
56,576.70 50,672.60 58,196.15 38,146.06 27,754.83
Total Debt* arrow
7,734.10 11,769.50 7,676.20 5,910.20 6,021.78
Net Current Assets arrow
13,431.90 4,194.20 14,669.74 11,376.14 446.95
Contingent Liabilities arrow
336.14 989.90 1,358.37 1,094.02 924.77

Cashflow (₹ Cr)

Dr. Reddy'S Labs Zydus Lifesciences Aurobindo Pharma Lupin Mankind Pharma
Cash From Operating Activities arrow
5,673.70 2,116.60 5,526.37 7,334.50 3,121.29
Cash Flow from Investing Activities arrow
-6,549.30 -8,296.10 -3,458.61 -3,864.59 -196.42
Cash from Financing Activities arrow
829.00 5,806.90 -1,269.15 -845.87 -2,952.69
Net Cash Inflow / Outflow arrow
-46.60 -372.60 798.61 2,624.04 -27.82

Ratios

Profitability Ratios

 Dr. Reddy'S Labs Zydus Lifesciences Aurobindo Pharma Lupin Mankind Pharma
ROCE (%) arrow
13.75 21.39 12.76 28.86 13.24
ROE (%) arrow
8.72 18.78 10.38 28.32 13.60
ROA (%) arrow
5.89 10.03 6.86 16.43 7.36
EBIT Margin (%) arrow
9.09 19.35 14.96 26.73 19.91
Net Margin (%) arrow
9.15 14.92 10.42 18.23 13.64
Cash Profit Margin (%) arrow
0.00 0.00 0.00 0.00 0.00

Growth Ratios

 Dr. Reddy'S Labs Zydus Lifesciences Aurobindo Pharma Lupin Mankind Pharma
Revenue Growth (%) arrow
-0.87 21.11 9.09 28.19 14.16
EBIT Growth (%) arrow
-55.06 -8.99 6.91 77.03 19.45
Net Profit Growth (%) arrow
-44.66 -3.14 8.63 49.13 8.09
EPS Growth (%) arrow
-43.29 4.31 11.88 60.86 12.27
Book Value Growth (%) arrow
12.99 13.19 16.04 30.75 13.74

Valuation Ratios

 Dr. Reddy'S Labs Zydus Lifesciences Aurobindo Pharma Lupin Mankind Pharma
Price / Earnings arrow
31.39 23.70 25.98 16.26 47.65
Price / Book Value arrow
2.65 4.30 2.51 4.07 6.09
Dividend Yield (%) arrow
0.66 0.09 0.24 0.85 0.04
EV/EBITDA arrow
19.82 16.59 13.37 9.82 27.81
Market Cap (₹ Cr) arrow
1,04,763.81 87,643.18 75,689.14 1,05,737.27 82,801.75

Solvency Ratios

 Dr. Reddy'S Labs Zydus Lifesciences Aurobindo Pharma Lupin Mankind Pharma
Debt to Equity arrow
0.00 0.12 0.02 0.07 0.17
Short term debt to equity ratio arrow
0.16 0.16 0.16 0.18 0.04
Current Ratio arrow
1.80 1.27 1.81 1.90 1.07
Quick Ratio arrow
1.35 0.91 1.15 1.42 0.74
Interest Coverage arrow
10.67 12.77 14.98 17.52 5.41

Operating Efficiency Ratios

 Dr. Reddy'S Labs Zydus Lifesciences Aurobindo Pharma Lupin Mankind Pharma
Debtors to sales (%) arrow
30.47 18.94 20.31 22.04 11.74
Asset Turnover arrow
0.62 0.64 0.65 0.89 0.53
Receivable days arrow
103.79 33.55 33.71 51.23 39.93
Inventory Days arrow
79.94 33.80 59.32 48.93 51.78
Payable days arrow
84.78 149.82 148.20 205.75 111.46
Cash Conversion Cycle arrow
98.95 -82.46 -55.17 -105.59 -19.75
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
loading...